Journal of Oncology / 2021 / Article / Tab 2 / Research Article
Construction, Validation, and Visualization of Two Web-Based Nomograms to Predict Overall and Cancer-Specific Survival in Patients with Gastric Cancer and Lung Metastases Table 2 Baseline data of clinicopathological characteristics of patients with GCLM in CSS group.
Variables Total cohort (N = 524) Training cohort (N = 368) Validation cohort (N = 156) n % n % n % Age <60 197 37.6 131 35.6 66 42.3 ≥60 327 62.4 237 64.4 90 57.7 Race Black 67 12.8 50 13.6 17 10.9 Other 69 13.2 49 13.3 20 12.8 White 388 74 269 73.1 119 76.3 Sex Female 162 30.9 109 29.6 53 34.0 Male 362 69.1 259 70.4 103 66.0 Histologic type Adenocarcinoma 340 64.9 247 67.1 93 59.6 Signet ring cell 76 14.5 46 12.5 30 19.2 Intestinal type 36 6.9 26 7.1 10 6.4 Other 72 13.7 49 13.3 23 14.7 T stage T1 209 39.9 148 40.2 61 39.1 T2 36 6.9 27 7.3 9 5.8 T3 117 22.3 84 22.8 33 21.2 T4 162 30.9 109 29.6 53 34.0 N stage N0 207 39.5 144 39.1 63 40.4 N1 254 48.5 187 50.8 67 42.9 N2 26 5 14 3.8 12 7.7 N3 37 7.1 23 6.3 14 9.0 Grade Grade I 19 3.6 15 4.1 4 2.6 Grade II 147 28.1 105 28.5 42 26.9 Grade III 349 66.6 242 65.8 107 68.6 Grade IV 9 1.7 6 1.6 3 1.9 Bone metastasis No 432 97.1 303 82.3 129 82.7 Yes 92 2.9 65 17.7 27 17.3 Liver metastasis No 257 49 179 48.6 78 50.0 Yes 267 51 189 51.4 78 50.0 Brain metastasis No 509 97.1 356 96.7 153 98.1 Yes 15 2.9 12 3.3 3 1.9 Primary site Cardia 240 45.8 164 44.6 76 48.7 Fundus 33 6.3 22 6 11 7.1 Body 38 7.3 29 7.9 9 5.8 Gastric antrum 63 12 46 12.5 17 10.9 Lesser 20 3.8 11 3 9 5.8 Greater 24 4.6 19 5.2 5 3.2 Other 106 20.2 77 20.9 29 18.6 Radiotherapy No 401 76.5 276 75 125 80.1 Yes 123 23.5 92 25 31 19.9 Chemotherapy No 205 39.1 158 42.9 47 30.1 Yes 319 60.9 210 57.1 109 69.9 Surgery No 481 91.8 340 92.4 141 90.4 Yes 43 8.2 28 7.6 15 9.6 Marital status No 209 39.9 152 41.3 57 36.5 Yes 315 60.1 216 58.7 99 63.5 Insurance No 31 5.9 22 6 9 5.8 Yes 493 94.1 346 94 147 94.2